These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3165066)

  • 41. Duchenne muscular dystrophy in Wales: impact of DNA linkage analysis and cDNA deletion screening.
    Norman AM; Upadhyaya M; Thomas NS; Roberts K; Harper PS
    J Med Genet; 1989 Sep; 26(9):565-71. PubMed ID: 2810340
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Carrier detection and gene analysis in a Duchenne muscular dystrophy family].
    Lu FM
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1990 Aug; 23(4):231-3, 255. PubMed ID: 1979269
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Molecular-genetic study of Duchenne and Becker muscular dystrophies: deletion analyses of 45 Japanese patients and segregation analyses in their families with RFLPs based on the data from normal Japanese females.
    Sugino S; Fujishita S; Kamimura N; Matsumoto T; Wapenaar MC; Deng HX; Shibuya N; Miike T; Niikawa N
    Am J Med Genet; 1989 Dec; 34(4):555-61. PubMed ID: 2576185
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Molecular probe protocol for determining carrier status in Duchenne and Becker muscular dystrophies.
    Prior TW; Friedman KJ; Highsmith WE; Perry TR; Silverman LM
    Clin Chem; 1990 Mar; 36(3):441-5. PubMed ID: 1968788
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Molecular diagnosis of Duchenne and Becker muscular dystrophies. Current data].
    Junien C; Boué J; Duros C; Coulon M; Cohen P; Dehaupas I; Gallano P; Léotard B; Nicolas H; Boué A
    Ann Genet; 1987; 30(1):5-16. PubMed ID: 3498430
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Localization and cloning of Xp21 deletion breakpoints involved in muscular dystrophy.
    Monaco AP; Bertelson CJ; Colletti-Feener C; Kunkel LM
    Hum Genet; 1987 Mar; 75(3):221-7. PubMed ID: 2881877
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prenatal diagnosis of Duchenne muscular dystrophy: a three-year experience in a rapidly evolving field.
    Bakker E; Bonten EJ; Veenema H; den Dunnen JT; Grootscholten PM; van Ommen GJ; Pearson PL
    J Inherit Metab Dis; 1989; 12 Suppl 1():174-90. PubMed ID: 2509804
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Rapid direct diagnosis of deletions carriers of Duchenne and Becker muscular dystrophies.
    Fassati A; Tedeschi S; Bordoni A; Amboni P; Curcio C; Bresolin N; Scarlato G
    Lancet; 1994 Jul; 344(8918):302-3. PubMed ID: 7914263
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Linkage analysis of a DNA polymorphism proximal to the Duchenne and Becker muscular dystrophy loci on the short arm of the X chromosome.
    Brown CS; Pearson PL; Thomas NS; Sarfarazi M; Harper PS; Shaw DJ
    J Med Genet; 1985 Jun; 22(3):179-81. PubMed ID: 2989525
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Isolation of probes detecting restriction fragment length polymorphisms from X chromosome-specific libraries: potential use for diagnosis of Duchenne muscular dystrophy.
    Hofker MH; Wapenaar MC; Goor N; Bakker E; van Ommen GJ; Pearson PL
    Hum Genet; 1985; 70(2):148-56. PubMed ID: 2989153
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Carrier detection and prenatal diagnosis in Duchenne and Becker muscular dystrophy families, using dinucleotide repeat polymorphisms.
    Clemens PR; Fenwick RG; Chamberlain JS; Gibbs RA; de Andrade M; Chakraborty R; Caskey CT
    Am J Hum Genet; 1991 Nov; 49(5):951-60. PubMed ID: 1928100
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Detection of carriers of X-linked gene for Duchenne muscular dystrophy by levels of creatine kinase and pyruvate kinase.
    Falcão-Conceição DN; Gonçalves-Pimentel MM; Baptista ML; Ubatuba S
    J Neurol Sci; 1983 Dec; 62(1-3):171-80. PubMed ID: 6668472
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Use of DNA probes in detecting carriers of Duchenne muscular dystrophy: selected case studies.
    Prior TW; Blasco PA; Dove JL; Leshner RT; Gruemer HD
    Clin Chem; 1989 Apr; 35(4):679-83. PubMed ID: 2564818
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The use of flanking markers in prediction for Duchenne muscular dystrophy.
    Williams H; Sarfarazi M; Brown C; Thomas N; Harper PS
    Arch Dis Child; 1986 Mar; 61(3):218-22. PubMed ID: 3457554
    [TBL] [Abstract][Full Text] [Related]  

  • 55. DNA diagnostic tests in Xp21 dystrophy families for prenatal diagnosis.
    Dinçer P; Topaloğlu H; Ayter S
    Turk J Pediatr; 1998; 40(3):347-55. PubMed ID: 9763898
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Deletion screening and prenatal diagnosis of Duchenne muscular dystrophy using cDNA probes Cf 23a and Cf 56a.
    Herrmann FH; Wulff K; Schütz M; Wehnert M
    Eur J Pediatr; 1990 Jan; 149(4):263-5. PubMed ID: 1968008
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A new method for the analysis of age trends in CPK levels with application to Duchenne muscular dystrophy.
    Lange K; Zatz M
    Hum Hered; 1979; 29(3):154-60. PubMed ID: 468274
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Manifesting carrier of Becker muscular dystrophy (BMD): clinical and recombinant DNA studies.
    Ionasescu VV; Searby CC; Ionasescu R
    Acta Neurol Scand; 1989 Jun; 79(6):500-3. PubMed ID: 2782030
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prenatal diagnosis and detection of carriers with DNA probes in Duchenne's muscular dystrophy.
    Darras BT; Harper JF; Francke U
    N Engl J Med; 1987 Apr; 316(16):985-92. PubMed ID: 3561454
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Carrier detection by DNA analysis in Duchenne muscular dystrophy families.
    Battaloğlu E; Telatar M; Deymeer F; Serdaroğlu P; Ozdemir C; Kuseyri F; Apak MY; Tolun A
    Turk J Pediatr; 1992; 34(2):79-92. PubMed ID: 1440954
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.